Aglatimagene Besadenovec Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

Candel Therapeutics, Inc.1

Indications

Non-Squamous Non-Small Cell Lung Cancer1
Lung Cancer1
Cancer1

New York, New York1 trial

Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.